scholarly article | Q13442814 |
P356 | DOI | 10.1097/FJC.0B013E3181F603D0 |
P953 | full work available at URL | http://journals.lww.com/00005344-201101000-00001 |
P698 | PubMed publication ID | 20729755 |
P2093 | author name string | Eva van Rooij | |
Rusty L. Montgomery | |||
P2860 | cites work | MicroRNAs as targets for antisense-based therapeutics | Q37032639 |
Heart failure | Q53998058 | ||
Heart failure | Q73397364 | ||
The nuclear RNase III Drosha initiates microRNA processing | Q24295234 | ||
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs | Q24302072 | ||
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing | Q24306121 | ||
The Microprocessor complex mediates the genesis of microRNAs | Q24312976 | ||
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs | Q24537328 | ||
MicroRNA genes are transcribed by RNA polymerase II | Q24562649 | ||
miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy | Q24598242 | ||
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver | Q24649633 | ||
MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes | Q24650009 | ||
MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths | Q24653709 | ||
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure | Q27691424 | ||
Asymmetry in the assembly of the RNAi enzyme complex | Q27860763 | ||
Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 | ||
Processing of primary microRNAs by the Microprocessor complex | Q27860986 | ||
Functional siRNAs and miRNAs Exhibit Strand Bias | Q27861038 | ||
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 | Q28285980 | ||
MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis | Q28509140 | ||
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 | ||
LNA-mediated microRNA silencing in non-human primates | Q29615962 | ||
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells | Q29616080 | ||
MicroRNA-133 controls cardiac hypertrophy | Q29616572 | ||
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
MicroRNAs add a new dimension to cardiovascular disease | Q33761132 | ||
2'-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation | Q33916133 | ||
miR-33 links SREBP-2 induction to repression of sterol transporters | Q33981907 | ||
Clinical practice. Systolic heart failure. | Q34093912 | ||
Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma | Q34119365 | ||
Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? | Q34455538 | ||
Small-molecule inhibitors of microrna miR-21 function | Q36192700 | ||
2'-Modified oligonucleotides for antisense therapeutics | Q36789789 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
P304 | page(s) | 1-7 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | Journal of Cardiovascular Pharmacology | Q2125808 |
P1476 | title | Therapeutic advances in MicroRNA targeting | |
Therapeutic Advances in MicroRNA Targeting | |||
P478 | volume | 57 |
Q34059809 | Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations |
Q37723852 | Can exercise teach us how to treat heart disease? |
Q54976146 | Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise. |
Q35735278 | Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. |
Q38085345 | Function and fate of myofibroblasts after myocardial infarction |
Q36025533 | Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction |
Q34292584 | Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice |
Q35206513 | Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury |
Q39351982 | Interfering nanoparticles for silencing microRNAs |
Q38954524 | MiR-146a/b: a family with shared seeds and different roots. |
Q38679814 | MicroRNA in the Diseased Pulmonary Vasculature: Implications for the Basic Scientist and Clinician. |
Q36849434 | MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6 |
Q34145885 | MicroRNA-708 regulates CD38 expression through signaling pathways JNK MAP kinase and PTEN/AKT in human airway smooth muscle cells |
Q38267957 | MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective. |
Q51793583 | MicroRNAs in liver disease. |
Q37584292 | Prospects of miRNA-based therapy for pancreatic cancer |
Q33827444 | Roles of lncRNAs in pancreatic beta cell identity and diabetes susceptibility. |
Q29039090 | Silencing disease genes in the laboratory and the clinic |
Q38285749 | Strategies to antagonize miRNA functions in vitro and in vivo |
Q35966911 | The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders |
Q38103313 | The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes? |
Search more.